Bono, A.; La Monica, G.; Alamia, F.; Tocco, D.; Lauria, A.; Martorana, A.
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents. Pharmaceuticals 2025, 18, 1579.
https://doi.org/10.3390/ph18101579
AMA Style
Bono A, La Monica G, Alamia F, Tocco D, Lauria A, Martorana A.
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents. Pharmaceuticals. 2025; 18(10):1579.
https://doi.org/10.3390/ph18101579
Chicago/Turabian Style
Bono, Alessia, Gabriele La Monica, Federica Alamia, Dennis Tocco, Antonino Lauria, and Annamaria Martorana.
2025. "A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents" Pharmaceuticals 18, no. 10: 1579.
https://doi.org/10.3390/ph18101579
APA Style
Bono, A., La Monica, G., Alamia, F., Tocco, D., Lauria, A., & Martorana, A.
(2025). A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents. Pharmaceuticals, 18(10), 1579.
https://doi.org/10.3390/ph18101579